DOI: https://doi.org/10.22141/1608-1706.2.19.2018.130650
Effectiveness of Nimedar application in orthopedic practice
Abstract
Keywords
Full Text:
PDF (Українська)References
Bennet A., Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities // Exp. Opin. Pharmacother. — 2000. — 1. — 277-286.
Bernareggi A. Clinical pharmacokinetics of nimesulide // Clin. Pharmacokinet. — 1998. — 35(4). — 247-274.
Bevilacqua M., Devogelaer J.P., Righini V., Famaey J.P., Manicourt D.H. Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study // Int. J. Clin. Pract. Suppl. — 2004. — 144. — 13-19.
Bianchi M., Ferrario P., Balzarini P., Broggini M. Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis // J. Int. Med. Res. — 2006. — 34. — 348-354.
Bloodsworth A., O’Donnell V.B., Freeman B.A. Nitric oxide regulation of free radical and enzyme mediated lipid and lipoprotein oxidation // Aterioscler. Thromb. Vasc. Biol. — 2000. — 20(7). — 1707-1715.
Casolaro V., Meliota S., Marino O. et al. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells // J. Pharmacol. Exp. Ther. — 1993. — 267(3). — 1375-85.
Conforti A., Leone R., Moretti U., Mozzo F., Velo G. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area // Drug Saf. — 2001. — 24(14). — 1081-1090.
Famaey J.P. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview // Inflamm. Res. — 1997. — 46. — 437-46.
Grossman C.J., Wiseman J., Lucas F.S. et al. Inhibition of constitutive and inducible cyclo-oxygenase activity in human platelets and mononuclear cells by NSAIDs and COX 2 inhibitors // Inflam. Res. — 1995. — 44. — 253-7.
Henrotin Y.E., Labasse A.H., Simonis P.E. et al. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro // Clin. Exp. Rheumatol. — 1999. — 17. — 151-160.
Kullich W.C., Niksic F., Klein G. Effect of nimesulide on metalloproteinases and matrix degradation in osteoarthritis: a pilot clinical study // Int. J. Clin. Pract. Suppl. — 2002. — 128. — 24-29.
Laporte J.R., Ibanez L., Vidal X. et al. Upper gastrointestinal bleedings, associated with the use of NSAIDs: newer versus older agents // Drug. Saf. — 2004. — 27(6). — 411-420.
Pelletier J.P., Di Battista J.A., Zhang M. et al. Effect of nimesulide on glucocorticoid receptor activity in human synovial fibroblasts // Rheumatology. — 1999. — 38 (Suppl. 1). — 11-13.
Pelletier J.P., Mineau F., Fernandes J.C. et al. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts // Clin. Exp. Rheumatol. — 1997. — 15. — 393-398.
Rainsford K. and Members of the Consensus Report Group on Nimesulide. Nimesulide — a multifactorial approach to inflammation and pain: scientific and clinical consensus // Current Medical Research and Opinion. — 2006. — 22(2). — 1161-1170.
Rainsford K.D. Nimesulide: overview of properties and applications // Drugs of Today. — 2001. — 37 (Suppl. B). — 3-7.
Rainsford K.D. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions // Rheumatol. (Oxford). — 1999. — 38 (Suppl. 1). — 4-10.
Rossoni G., Berti F., Buschi A. et al. New data concer-ning the antianaphylactic and antihistaminic activity of nimesulide // Drugs. — 1993. — 46 (Suppl. 1). — 22-28.
Scher J.U., Pillinger M.H., Abramson S.B. Nitric
oxide synthases and osteoarthritis // Curr. Rheumatol. Rep. — 2007. — 9(1). — 9-15.
Кузьменко В.В., Фокин В.А., Маттис Э.Р., Соков Е.Л., Бармотин Г.В., Назарова Т.Б. Психологические методы количественной оценки боли // Советская медицина. — 1986. — 10. — С. 44-48.
Atlas S.J. The Quebec Task Force classification for Spinal Disorders and severity,treatment and outcomes of shiatica and lumbar spinal stenosis / S.J. Atlas, R.A. Deyo, D.L. Patrick et al. // Spine. — 1996. — Vol. 21. — P. 2885-2892.
Copyright (c) 2018 TRAUMA

This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018
